Skip to main content
. 2023 Nov 3;14:7053. doi: 10.1038/s41467-023-42635-2

Fig. 3. Event-free survival outcomes based on the groups identified by the prognostic HER2-EveNT score in the NeoALTTO dataset.

Fig. 3

a Kaplan–Meier plot showing EFS in the NeoALTTO population (N = 233) with information available for all variables included in the model (breast pCR, hormone receptor status, clinical nodal status, TILs, BCR evenness). b Kaplan–Meier plot showing EFS in the NeoALTTO subgroup with all variables in the model available and breast pCR (ypT0/is) at surgery (N = 82). c Kaplan–Meier plot showing EFS in the NeoALTTO subgroup with all variables in the model available and without pCR in the breast at surgery (N = 151). Patients are stratified according to low risk (good prognosis group, first tertile) and high risk (poor prognosis group, tertiles 2 and 3 combined), based on the HER2-EveNT score derived from the prognostic model. Tables show 5-year EFS rates and HRs with respective 95% CI. P values are from log-rank test, HR describes the risk of an event as defined by EFS in the good prognosis group compared to the one with poor prognosis. 95% CI 95% confidence interval, BCR B cell receptor, EFS event-free survival, HR hazard ratio, pCR pathological complete response, TILs tumor-infiltrating lymphocytes.